Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,

Slides:



Advertisements
Similar presentations
Do you require any assistance? Do you experience any symptoms? Calit2 Summer Research Program Minimize Hypoglycemic Episodes Utilizing Remote Assistance.
Advertisements

Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
LSU-HSC School of Public Health Biostatistics 1 Statistical Core Didactic Introduction to Biostatistics Donald E. Mercante, PhD.
INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Measures of Variability
1 INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS H. Peter Chase, MD Vicky Gage, RN, CDE Laurel Messer, RN, CDE Susie Owen, RN, CDE Sally Sullivan, RN, CDE.
1 Progress Towards an Artificial Pancreas for T1D WILLIAM TAMBORLANE, MD Chief of Pediatric Endocrinology, Yale University, Deputy Director, Yale Center.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
IDR Snapshot: Quantitative Assessment Methodology Evaluating Size and Comprehensiveness of an Integrated Data Repository Vojtech Huser, MD, PhD a James.
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
Determining Sample Size
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
Diabetes Technology Update
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
© Copyright 2009 by the American Association for Clinical Chemistry Glucose Meter Performance Criteria for Tight Glycemic Control Estimated by Simulation.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
N318b Winter 2002 Nursing Statistics Lecture 2: Measures of Central Tendency and Variability.
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
ABSTRACT Hyperglycaemia is prevalent in critical care, and tight control reduces mortality. Targeted glycaemic control can be achieved by frequent fitting.
Relative Values. Statistical Terms n Mean:  the average of the data  sensitive to outlying data n Median:  the middle of the data  not sensitive to.
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Biostatistics Case Studies 2006 Peter D. Christenson Biostatistician Session 2: Correlation of Time Courses of Simultaneous.
INTRODUCTION The Solution: Point-of-care (POC) continuous glucose sensors offer significant promise for real-time control and artificial pancreas systems.
Session 6: Other Analysis Issues In this session, we consider various analysis issues that occur in practice: Incomplete Data: –Subjects drop-out, do not.
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
Uncertainty2 Types of Uncertainties Random Uncertainties: result from the randomness of measuring instruments. They can be dealt with by making repeated.
Chapter 6: Descriptive Statistics. Learning Objectives Describe statistical measures used in descriptive statistics Compute measures of central tendency.
Intensive Reading Support 6.0 Evaluate Instructional Support
Hospital inpatient data James Hebblethwaite. Acknowledgements This presentation has been adapted from the original presentation provided by the following.
Review Design of experiments, histograms, average and standard deviation, normal approximation, measurement error, and probability.
1 INTRODUCTION Nearly 25% of diabetes patients use insulin Many practitioners: –Are uncomfortable with insulin dosing –Base dosing decisions on empiric.
Estimation of blood glucose in diabetes mellitus.
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
Daniel A. Baur, Fernanda S. Vargas, Jordan A. Garvey, Christopher W. Bach, and Michael J Ormsbee, FACSM Institute of Sports Sciences and Medicine, Department.
Estimation of blood glucose in diabetes mellitus
Statistical Core Didactic
Lab 2 Presentation of Data Part I
Copyright © 2004 American Medical Association. All rights reserved.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Best Practices in Advanced Glucose Monitoring
Management of perioperative hypertension
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
in Youth With Type 1 Diabetes
Presentation transcript:

Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson, 2 Roy Beck 1 and William Tamborlane 3 for the Diabetes Research in Children Network (DirecNet) Study Group 1. Tampa, FL; 2. Stanford, CA; 3. New Haven, CT;

Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson, 2 Roy Beck 1 and William Tamborlane 3 for the Diabetes Research in Children Network (DirecNet) Study Group 1 Tampa, FL; 2 Stanford, CA; 3 New Haven, CT;. Currently, the accuracy of near-continuous glucose sensors is typically assessed using point-by-point comparisons. While useful in evaluating meters, these methods can be skewed by important temporal aspects of hypo- or hyperglycemic excursions. To compare event-based vs. point-by-point analyses of accuracy during exercise-induced falls in plasma glucose, we studied 22 children with T1D 8-17 y who wore a Freestyle Navigator Continuous Glucose Monitoring System (Abbott Diabetes Care, Alameda, CA) during a 24h CRC admission that included an exercise session. Blood samples for reference laboratory glucose measurements were taken q15 min during exercise. Three subjects were excluded from analysis because the blood samples were insufficient for laboratory measurements (N=1) or the glucose did not fall during exercise (N=2). Point-by-point analysis resulted in a median relative absolute difference (RAD) of 17% during exercise compared with 12% during non-exercise. Event analysis looking at the entire glycemic excursion (baseline to nadir) shows this discrepancy was primarily accounted for by a slower rate of fall in Navigator vs reference values (median 0.8 vs 1.4 mg/dL/min; p<0.001) and by a 5-30 min lag between the nadir Navigator and reference glucose levels (median 100 vs 75 min, respectively p<0.001). The sensor-measured fall was similar to that of the reference in each patient (figure). Point-by-point estimates of error can be unduly inflated by sensor lag during periods of rapid change. Event-based methods offer a simple way to incorporate the time dimension into analyses without a complicated or arbitrary adjustment for lag. Abstract

Introduction Many techniques used to assess the accuracy of near-continuous glucose sensors are borrowed from methods developed for meters. Rely on point-by-point comparisons. Do not assess trends over time. Event-based methods intended to incorporate the time element into analyses in a clinically meaningful way.

Point-by-Point Analysis Each glucose reading is paired to a reference measurement (within a few minutes). Sensor readings often adjusted for a fixed time lag. Difference measures calculated for each pair used to describe accuracy.

Point-by-Point Analysis Example with Hourly Reference Sampling Pair #1 Pair #2Pair #3

Point-by-Point Analysis Example Measures of Accuracy Difference: Sensor minus reference. Absolute Difference: Absolute value of Difference (always positive). Relative Absolute Difference (RAD): Absolute Difference divided by reference (expressed as a percentage). ISO Criteria: If reference ≤75 mg/dL sensor within ±15mg/dL; if reference>75 mg/dL sensor within ±20%. Error Grid: (Clarke or Consensus): Zone A or B.

Point-by-Point Analysis Previous Example Revisited Pair #1Pair #2Pair #3 Sensor Glucose Reference Glucose Difference+17+30–14 Absolute Difference RAD12%21%8% ISO Criteria MetYesNoYes Zone A or BYesYesYes

Point-by-Point Analysis Consensus Error Grid

Event Analysis Combine multiple points into clinically meaningful events. Define events to capture more of the time element. Example events would be hypo- or hyperglycemic episodes or hypo- or hyperglycemic excursions. Define difference measures based on the entire event rather than individual points. Requires more frequent reference sampling.

Event Analysis Defining Excursions Define the hypoglycemic excursion as the drop in glucose from baseline to nadir. Calculate separately for sensor vs. reference. Calculate rate of change from baseline until the nadir. Note the sensor and reference nadirs will often occur at different times. Rates of change therefore calculated over slightly different time periods.

Event Analysis Example Comparison of Hypoglycemic Excursions Reference Nadir Sensor Baseline Sensor Nadir Reference Baseline

Event Analysis Calculate Excursion Summaries from Previous Graph SensorReference Baseline Glucose Nadir Glucose Drop in Glucose = =61 Minutes to Nadir8050 Rate of Change*58÷80=0.761÷50=1.2 * mg/dL/minute.

Event Analysis Hypoglycemic Events Multiple glucose readings below the hypoglycemic threshold (e.g., 70 mg/dL) considered part of the same event. Calculation of false positive and sensitivity rates based on events rather than individual points. Allow ±10 mg/dL margin of error (e.g., sensor=68/reference=72 not counted as a false positive). Allow ± 30 minute range from beginning of event to confirm a sensor low or detect a low reference. Analogous rules for hyperglycemic events.

Illustration Using Actual Data DirecNet Pilot Study of the FreeStyle Navigator™ Continuous Glucose Monitoring System, (Abbott Diabetes Care, Alameda, CA). One of the objectives was to assess accuracy. Type 1 diabetes for at least 1 year. Age 3 to <18 years. Using a downloadable insulin infusion pump for a least 6 months.

Study Procedures Admitted to Clinical Research Center –Approximately 24 hours Exercise session for those older than 7 yrs –Four 15-min sessions walking on a treadmill at a target heart rate 140 bpm interspersed with three 5- min rest breaks Venous blood sampling –Just prior to start of exercise (Baseline) –Each rest period –End of exercise Reference glucoses measured at DirecNet Central Laboratory.

Point-by-Point Analysis N=19 subjects Median (25 th, 75 th percentiles) DuringOther ExerciseTimes N=97 pairsN=1,203 pairs Difference+17 (+3, +27)0 (-16, +16) Absolute Difference22 (12, 33)16 (8, 28) RAD17% (9%, 26%)12% (6%, 20%) ISO Criteria58%75%

Event Analysis Hypoglycemic Excursions during Exercise N=19 Subjects Drop in Glucose from Baseline to Nadir (mg/dL)

Event Analysis Hypoglycemic Excursions during Exercise N=19 Subjects Rate of Change from Baseline to Nadir (mg/dL/minute)

Event Analysis Hypoglycemic Excursions during Exercise N=19 subjects median (25 th -75 th percentiles) NavigatorLabDifference Abs. Diff. Baseline (-26, +18) 23 (17, 36) Glucose Drop a (-27, +4) 17 (8, 28) Minutes to Nadir (-7, +14) 22 (13, 42) Rate of Change b (-0.8, -0.2) 0.4 (0.2, 0.8) a-baseline minus nadir; b-mg/dL/minute (timed from baseline to nadir)

Event Analysis Detection of Hypo- and Hyperglycemic events SensitivityFalse Positive Inpatient Hypoglycemia*49%37% Hyperglycemia**83%18% Outpatient Hypoglycemia*62%28% Hyperglycemia**87%12% * Multiple readings ≤70 mg/dL within 30 min treated as same event. ** Multiple readings ≥200 mg/dL within 30 min treated as same event.

Remarks Point-by-point analysis may give the impression that the Navigator did not perform well during exercise. However, the Navigator generally tracked the exercise-induced drops in glucose fairly well. Rate of change was less when estimated by the Navigator which may have reflected the longer time necessary for the compartment it measures to reach the nadir.

Summary Event-based analyses can be used to supplement point-by-point comparisons to further describe the clinical utility of near- continuous glucose sensors. Requires more frequent reference sampling than is necessary for point-by- point analysis. Comparison of glucose excursions does not require adjustment for a fixed lag time. Amount of lag can vary by subject and within the same subject over time.

Contact Information Craig Kollman Address: Jaeb Center for Health Research Amberly Dr. – Suite 350 Tampa, FL Phone:

Barbara Davis Center –H. Peter Chase –Rosanna Fiallo-Scharer –Laurel Messer –Barbara Tallant University of Iowa –Eva Tsalikian –Michael Tansey –Linda Larson –Julie Coffey –Joanne Cabbage Nemours Children’s Clinic –Tim Wysocki –Nelly Mauras –Larry Fox –Keisha Bird –Kim Englert Stanford University –Bruce Buckingham –Darrell Wilson –Jennifer Block –Paula Clinton Yale University –William Tamborlane –Stuart Weinzimer –Elizabeth Doyle –Melody Martin –Amy Steffen Jaeb Center for Health Research –Roy Beck –Katrina Ruedy –Craig Kollman –Dongyuan Xing –Cynthia Stockdale